-
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
-
Your Cancer Guide
Your Results Are AvailableWeb-based patient portals provide immediate access to test results and doctor's notes. But is that a good thing?
by Hester Hill Schnipper
-
Caregiving With Confidence
Addressing Depression Head-onCaregivers may need to advocate for themselves to get mental health support.
by K.J. Bannan
-
Healthy Habits
Plant PowerPlant-based diets may help people with prostate cancer reduce their risk for disease progression.
by Anne Danahy
-
Healthy Habits
Connection Is KeyResearch suggests social activity is beneficial for cancer survivors’ longevity.
by Erin O'Donnell
-
Q&A
Solving a Medical MysteryJournalist Lawrence Ingrassia traces the scientific history of a genetic disorder that predisposes families like his to cancer.
by Thomas Celona
-
Sound Advice
How Can People With Cancer Avoid Getting Lymphedema?Talk with your provider before surgery and stay active to help prevent this side effect.
-
Sound Advice
Can Cancer Survivors Donate Blood?The type of cancer and the time since treatment determine eligibility for blood donation.
-
Sound Advice
How Can I Help Protect a Loved One With Cancer From Falling?Monitor blood pressure and take precautions around the home to reduce the risk.
-
Facts and Stats
Financial FalloutNearly half of cancer survivors report their treatment left them in debt.
by Thomas Celona
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
